Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes

Ambrocio Sanchez1,2, Pedro Ortega1,2, Ramin Sakhtemani3,4

  • 1Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.

Nature Communications
|March 19, 2024
PubMed

Insights

The DNA-editing enzymes APOBEC3A and APOBEC3B generate distinct cancer mutation patterns. They target different DNA structures and sequences, influencing the resulting tumor genomes.

Area of Science:

  • Biochemistry
  • Genetics
  • Cancer Biology

Background:

  • Antiviral DNA cytosine deaminases APOBEC3A (A3A) and APOBEC3B (A3B) are key drivers of mutations in cancer.
  • These enzymes catalyze cytosine-to-uracil deamination, contributing to genomic instability.

Purpose of the Study:

  • To investigate the detailed substrate preferences of A3A and A3B.
  • To understand how specific DNA sequences influence the deaminase activity of A3A and A3B.
  • To determine if A3A and A3B generate distinct mutation patterns in cancer genomes.

Main Methods:

  • Development of Oligo-seq, an in vitro sequencing-based method.
  • Analysis of DNA stem-loop structures targeted by A3A and A3B.
  • Identification of sequence contexts and structural features governing deaminase activity.

Main Results:

  • A3B, like A3A, selectively targets DNA stem-loop structures, but distinct from those targeted by A3A.
  • A3A and A3B deaminase activity is strongly regulated by specific flanking sequences.
  • Mutations induced by A3B in hairpin sequences differ from those induced by A3A in tumor genomes.

Conclusions:

  • A3A and A3B exhibit unique substrate selectivity, leading to distinct mutation landscapes in cancer.
  • Understanding these preferences is crucial for deciphering cancer genome evolution and developing targeted therapies.